Yvonne Greenstreet Alnylam Pharmaceuticals, Inc. (ALNY) insider trading activity

Yvonne Greenstreet is Chief Executive Officer of ALNYLAM PHARMACEUTICALS, INC.. Currently has a direct ownership of 78,880 shares of ALNY, which is worth approximately $21 Million. The most recent transaction as insider was on Apr 19, 2021, when has been sold 5,083 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 78.9K

7.41% 3M change

123.99% 12M change

Total Value Held $21 Million

Yvonne Greenstreet Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 19 2021	BUY Grant, award, or other acquisition	-	5,083 Added 27.54%	13,374 Common Stock
Feb 12 2021	SELL Payment of exercise price or tax liability	$303,264 $155.92 p/Share	1,945 Reduced 19.0%	8,291 Common Stock
Feb 11 2021	BUY Grant, award, or other acquisition	-	5,416 Added 34.6%	10,236 Common Stock
Jan 12 2021	SELL Open market or private sale	$503,125 $161.0 p/Share	3,125 Reduced 39.33%	4,820 Common Stock
Jan 12 2021	BUY Exercise of conversion of derivative security	$131,938 $42.22 p/Share	3,125 Added 28.23%	7,945 Common Stock

Also insider at

PCRX

Pacira BioSciences, Inc. Healthcare

Director